-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Targeted therapies in oncology: perspectives on trial designs and practical considerations
Lindsay A Renfro, Sumithra J Mandrekar
Editorial: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dextromethorphan/quinidine for pseudobulbar affect
Steven L Dubovsky
Review: Clinical Trail Outcomes: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
Inclusion of patients with brain metastases in clinical trials
Lauren E Abrey
Editorial: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation